» Articles » PMID: 30387896

Neuropsychological Changes in Patients with Substance Use Disorder After Completion of a One Month Intensive Outpatient Treatment Program

Overview
Journal Am J Addict
Specialty Psychiatry
Date 2018 Nov 3
PMID 30387896
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Data suggest individuals with substance use disorders (SUD) exhibit high rates of executive functioning (EF) impairment, and that EF level can predict treatment retention. The primary aim of the present study was to investigate if patients who completed a 1 month intensive outpatient program (IOP) for SUD demonstrated recovered EF.

Methods: Baseline and follow-up neurocognitive functioning was assessed by the Cambridge Neuropsychological Test Automated Battery (CANTAB) and the self-reported Behavior Rating Inventory of Executive Functioning (BRIEF-A) questionnaire.

Results: The final sample included 15 patients who completed the one month IOP and for whom data were available (53% male, aged 36 years ± 13.4). Despite exhibiting general improvements in EF and significant improvements in organization, subjects continued to manifest significant executive dysfunction as evaluated by self-report and computerized assessment.

Conclusions And Scientific Significance: Patients with SUD often manifest high levels of executive dysfunction upon entry into SUD treatment that, while improving minimally, appears to persist despite intensive outpatient treatment at 1 month. These persistent EF deficits may affect patient engagement and participation in treatment, thus necessitating SUD programs to assess and accommodate EF issues throughout treatment. (Am J Addict 2018;XX:1-7).

Citing Articles

Assessment of cognitive functioning using the Mini Mental State Examination in men with Alcohol and Crack Cocaine Use Disorder.

Schuch J, Becker N, Rabelo-da-Ponte F, Ornell F, Freitas H, Rebelatto F Trends Psychiatry Psychother. 2023; 45:e20220567.

PMID: 36889679 PMC: 10597386. DOI: 10.47626/2237-6089-2022-0567.


Designing a Nurse-Led Program for Self-Management of Substance Addiction Consequences: A Modified e-Delphi Study.

Seabra P, Nunes I, Sequeira R, Sequeira A, Simoes A, Filipe F Int J Environ Res Public Health. 2023; 20(3).

PMID: 36767505 PMC: 9915323. DOI: 10.3390/ijerph20032137.

References
1.
Alegria A, Hasin D, Nunes E, Liu S, Davies C, Grant B . Comorbidity of generalized anxiety disorder and substance use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2010; 71(9):1187-95. PMC: 2951633. DOI: 10.4088/JCP.09m05328gry. View

2.
Robinson S, Sobell L, Sobell M, Leo G . Reliability of the Timeline Followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav. 2013; 28(1):154-62. DOI: 10.1037/a0030992. View

3.
Diamond A . Executive functions. Annu Rev Psychol. 2012; 64:135-68. PMC: 4084861. DOI: 10.1146/annurev-psych-113011-143750. View

4.
Bell M, Laws H, Petrakis I . A randomized controlled trial of cognitive remediation and work therapy in the early phase of substance use disorder recovery for older veterans: Neurocognitive and substance use outcomes. Psychiatr Rehabil J. 2016; 40(1):94-102. PMC: 5378626. DOI: 10.1037/prj0000211. View

5.
Beck A, Epstein N, Brown G, Steer R . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988; 56(6):893-7. DOI: 10.1037//0022-006x.56.6.893. View